ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Concerning myeloid malignancies, Zhao et al. found that β-catenin deletion causes a reduction in the ability of mice to develop BCR-ABL-induced CML (Zhao et al., 2007).